Eli Lilly announces $6.5B manufacturing plant in Houston, boosting investment from initial proposal

Lilly to build $6.5B Houston factory for its first obesity pill

The pharmaceutical giant is also planning a $5 billion manufacturing site in Virginia, with two more U.S. facilities expected to be announced later this year.

Eli Lilly announces second major investment in US manufacturing

The pharmaceutical company Eli Lilly announced on Tuesday that it will build a $6.5 billion facility in Texas, marking the company’s second multibillion-dollar U.S. investment this month. The Indiana-based company announced in February that it would be making four distinct manufacturing investments in 2025 across the United States, with the goal of bringing 13,000 domestic jobs to the American economy. Eli Lilly recently announced the first of t…

Lilly names Houston as site for $6.5bn API facility

Lilly has named Houston as the second of four locations for new manufacturing facilities that are central to a $27bn investment programme in the US.

Eli Lilly announces $6.5B manufacturing plant in Houston, boosting investment from initial proposal

Eli Lilly to Construct $6.5 Billion Manufacturing Facility in Houston

Pharmaceutical giant Eli Lilly and Company has announced plans to build a $6.5 billion manufacturing facility in Houston and is expected to create more than 4,600 manufacturing and construction jobs. Construction at the city’s Generation Park is slated to begin in 2026 and become fully operational by 2031. In a Sept. 23 statement, Lilly revealed it will be manufacturing next-generation synthetic medicine active pharmaceutical products at the Hou…

Eli Lilly announces weight-loss drug to be manufactured at $6.5 billion site in Houston

The multibillion-dollar investment will result in more than 600 permanent jobs, according to the company. The manufacturing hub is slated to be built at Generation Park near Lake Houston and will produce a new weight-loss drug.